切换至 "中华医学电子期刊资源库"

中华细胞与干细胞杂志(电子版) ›› 2019, Vol. 09 ›› Issue (01) : 50 -53. doi: 10.3877/cma.j.issn.2095-1221.2019.01.010

所属专题: 文献

综述

类器官的应用研究进展
张金梅1, 杨远荣1,()   
  1. 1. 434020 荆州,华中科技大学同济医学院附属荆州医院药学部
  • 收稿日期:2019-01-04 出版日期:2019-02-01
  • 通信作者: 杨远荣

Advances in the application of organoid

Jinmei Zhang1, Yuanrong Yang1,()   

  1. 1. Department of Pharmacy in Jingzhou Central Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Jingzhou 434020, China
  • Received:2019-01-04 Published:2019-02-01
  • Corresponding author: Yuanrong Yang
  • About author:
    Corresponding author:Yang Yuanrong, Email:
引用本文:

张金梅, 杨远荣. 类器官的应用研究进展[J]. 中华细胞与干细胞杂志(电子版), 2019, 09(01): 50-53.

Jinmei Zhang, Yuanrong Yang. Advances in the application of organoid[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2019, 09(01): 50-53.

类器官是利用干细胞的自我更新和分化能力,在体外培养形成的一种微小组织器官类似物,在很大程度上具有体内相应器官的功能。迄今为止,在3D培养条件下,已经成功培养出多种类器官如肺、胃、肠、肝和肾等类器官。它们不仅可作为组织器官的替代品用于药物和临床研究,还可用于体内器官移植。本文综述了类器官在药物毒性检测、药效评价和新药筛选中的作用以及利用类器官建立疾病模型、研究组织器官发育和类器官在精准医疗、再生医学中的价值。

Organoid is a kind of tiny tissue mimic cultured in vitro by employing self-?renew and differentiation abilities of stem cells.It has functions of its counterpart organ in vivo. So far, various organoids have been developed such as lung, gastric, intestinal, liver and kidney organoids under three-dimensional (3D) culture conditions. They are not only as alternatives of tissues or organs which can be exploited for drug development and clinical research, but also for organ transplantation.In this review, we recapitulate the roles of organoid in toxicity testing, drug evaluation and screening as well as in establishing disease model and in study of tissue development. Furthermore, we descreibe the use of organoid in precision medicine and regeneration medicine.

图1 类器官的形成及应用
[1]
Vlachogiannis G,Hedayat S,Vatsiou AA, et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers[J]. Science, 2018, 359(6378):920-926.
[2]
Katsuda T,Kawamata M,Hagiwara KA, et al. Conversion of terminally committed hepatocytes to culturable bipotent progenitor cells with regenerative capacity[J]. Cell Stem Cell, 2017, 20(1):41-55.
[3]
Voges HK,Mills RJ,Elliott DA, et al. Development of a human cardiac organoid injury model reveals innate regenerative potential[J]. Development, 2017, 144(6):1118-1127.
[4]
Takasato M,Er PX,Chiu HS, et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis[J]. Nature, 2015, 526(7574):564-568.
[5]
Huch M,Gehart H,Van Boxtel R, et al. Long-Term culture of Genome-Stable bipotent stem cells from adult human liver[J]. Cell, 2015, 160(1/2):299-312.
[6]
Pauli C,Hopkins BD,Prandi D, et al. Personalized in vitro and in vivo cancer models to guide precision medicine[J]. Cancer Discov, 2017, 7(5):462-477.
[7]
Van De Wetering M,Francies HE,Francis JM, et al. Prospective derivation of a living organoid biobank of colorectal cancer patients[J]. Cell, 2015, 161(4):933-945.
[8]
Fujii M,Shimokawa M,Date S, et al. A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis[J]. Cell Stem Cell, 2016, 18(6):827-838.
[9]
Dekkers JF,Berkers G,Kruisselbrink EA, et al. Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis[J]. Sci Transl Med, 2016, 8(344):344ra84.
[10]
Di Lullo E,Kriegstein AR. The use of brain organoids to investigate neural development and disease[J]. Nat Rev Neurosci, 2017, 18(10):573-584.
[11]
Li Y,Muffat J,Omer A, et al. Induction of expansion and folding in human cerebral organoids[J]. Cell Stem Cell, 2017, 20(3):385-396.
[12]
Firth AL,Menon T,Parker GS, et al. Functional gene correction for cystic fibrosis in lung epithelial cells generated from patient iPSCs[J]. Cell Rep, 2015, 12(9):1385-1390.
[13]
Ettayebi K,Crawford SE,Murakami K, et al. Replication of human noroviruses in stem cell-derived human enteroids[J]. Science, 2016, 353(6306):1387-1393.
[14]
Watanabe M,Buth JE,Vishlaghi N, et al. Self-Organized cerebral organoids with Human-Specific features predict effective drugs to combat Zika virus infection[J]. Cell Rep, 2017, 21(2):517-532.
[15]
Grabowski JM,Offerdahl DK,Bloom ME. The use of Ex vivo organ cultures in Tick-Borne virus research[J]. ACS Infect Dis, 2018, 4(3):247-256.
[16]
Jin MZ,Han RR,Qiu GZ, et al. Organoids: An intermediate modeling platform in precision oncology[J]. Cancer Lett, 2018, 414:174-180.
[17]
Es HA,Montazeri L,Aref AR, et al. Personalized cancer medicine: an organoid approach[J]. Trends Biotechnol, 2018, 36(4):358-371.
[18]
Seidlitz T,Merker SR,Rothe AA, et al. Human gastric cancer modelling using organoids[J]. Gut, 2019, 68(2):207-217.
[19]
Gao D,Vela I,Sboner A, et al. Organoid cultures derived from patients with advanced prostate cancer[J]. Cell, 2014, 159(1):176-187.
[20]
Mariani J,Coppola G,Zhang P, et al. FOXG1-Dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders[J]. Cell, 2015, 162(2):375-390.
[21]
Birey F,Andersen J,Makinson CD, et al. Assembly of functionally integrated human forebrain spheroids[J]. Nature, 2017, 545(7652):54.
[22]
Mccracken KW,Cata EM,Crawford CM, et al. Modelling human development and disease in pluripotent stem-cell-derived gastric organoids[J]. Nature, 2014, 516(7531):400.
[23]
Quadrato G,Nguyen T,Macosko EZ, et al. Cell diversity and network dynamics in photosensitive human brain organoids[J]. Nature, 2017, 545(7652):48-53.
[24]
Chen YW,Huang SX,de Carvalho ALRT, et al. A three-dimensional model of human lung development and disease from pluripotent stem cells[J]. Nat Cell Biol, 2017, 19(5):542-549.
[25]
Nie YZ,Zheng YW,Ogawa M, et al. Human liver organoids generated with single donor-derived multiple cells rescue mice from acute liver failure[J]. Stem Cell Res Ther, 2018, 9(1):5-17.
[26]
Sampaziotis F,Justin AW,Tysoe OC, et al. Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids[J]. Nat Med, 2017, 23(8):954.
[27]
Loomans CJ,Giuliani NW,Balak J, et al. Expansion of adult human pancreatic tissue yields organoids harboring progenitor cells with endocrine differentiation potential[J]. Stem Cell Reports, 2018, 10(3):712-724.
[28]
Shahjalal HM,Dayem AA,Lim KM, et al. Generation of pancreatic cells for treatment of diabetes: advances and challenges[J]. Stem Cell Res Ther, 2018, 9(1):355.
[29]
Llonch S,Carido M,Ader M. Organoid technology for retinal repair[J]. Dev Biol, 2018, 433(2, SI):132-143.
[30]
Deng WL,Gao ML,Lei XL, et al. Gene correction reverses ciliopathy and photoreceptor loss in iPSC-Derived retinal organoids from retinitis pigmentosa patients[J]. Stem Cell Reports, 2018, 10(4):1267-1281.
[1] 闫甲, 刘双池, 王政宇. 胆囊癌肿瘤标志物的研究和应用进展[J]. 中华普通外科学文献(电子版), 2023, 17(05): 391-394.
[2] 江文诗, 何湘湘. 全球及我国器官捐献发展特征分析与学科建设[J]. 中华移植杂志(电子版), 2023, 17(05): 280-286.
[3] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会, 上海医药行业协会. 中国肝、肾移植受者霉酚酸类药物应用专家共识(2023版)[J]. 中华移植杂志(电子版), 2023, 17(05): 257-272.
[4] 巨春蓉, 何建行, 钟南山. 咪唑立宾在器官移植领域的应用及展望[J]. 中华移植杂志(电子版), 2023, 17(04): 227-231.
[5] 中国康复医学会器官移植康复专业委员会. 成人实体器官移植后糖尿病管理专家共识[J]. 中华移植杂志(电子版), 2023, 17(04): 205-220.
[6] 艾紫叶, 李玲, 何重香, 黄伟, 叶啟发. 猪器官异种移植研究进展[J]. 中华移植杂志(电子版), 2023, 17(03): 186-191.
[7] 杨锦然, 李新长, 何小平, 傅俊, 龙成美, 陈志铭. 不破坏膈肌式肝肾联合获取术总结分析[J]. 中华移植杂志(电子版), 2023, 17(03): 146-151.
[8] 刘剑戎, 范明明, 郭煜. 器官捐献者转介时的临床特征分析[J]. 中华移植杂志(电子版), 2023, 17(03): 129-133.
[9] 国家传染病医学中心, 中华医学会器官移植学分会, 中国康复医学会器官移植康复专业委员会, 中国器官移植发展基金会器官移植受者健康管理专项基金. 实体器官移植受者新型冠状病毒感染诊疗专家共识(2023年版)[J]. 中华移植杂志(电子版), 2023, 17(02): 65-81.
[10] 陈琦, 郭嘉瑜, 陈忠宝, 马枭雄, 王天宇, 邹寄林, 张龙, 蔡治涛, 邱涛, 周江桥. 心肾联合移植三例[J]. 中华移植杂志(电子版), 2023, 17(02): 124-127.
[11] 陈琦, 郭嘉瑜, 陈忠宝, 马枭雄, 王天宇, 邹寄林, 张龙, 蔡治涛, 邱涛, 周江桥. 新型冠状病毒感染流行下我国器官捐献者筛选规则是否应时而变?[J]. 中华移植杂志(电子版), 2023, 17(02): 82-88.
[12] 中国器官移植发展基金会器官移植受者健康管理专家委员会. 器官移植受者新型冠状病毒感染防治策略与健康管理中国专家指导意见(第一版)[J]. 中华移植杂志(电子版), 2023, 17(01): 1-12.
[13] 向莹莹, 伯雪, 冯欢, 李军, 褚玲玲. 基于"互联网+"精准医疗服务的发展现状[J]. 中华肺部疾病杂志(电子版), 2023, 16(01): 143-144.
[14] 赵子祯, 严紫娟, 王家传. 脑类器官培养技术进展及其在缺血性脑卒中损伤修复中的应用[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(02): 121-128.
[15] 阎凯, 付雍, 章正涛, 卢文峰, 王毅州, 巫国谊, 张海斌. 中晚期肝癌疗效预测模型暨肝癌类器官模型研究进展[J]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 348-351.
阅读次数
全文


摘要